Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tamonwan Uttarawichien"'
Autor:
San Yoon Nwe, Tamonwan Uttarawichien, Teerawat Boonsom, Wisuwat Thongphichai, Peththa Wadu Dasuni Wasana, Boonchoo Sritularak, Witchuda Payuhakrit, Suchada Sukrong, Pasarapa Towiwat
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionBenign prostatic hyperplasia (BPH) is the enlargement of the prostate gland, primarily occurring in aging men, in which transforming growth factor-beta (TGF-β) plays a critical role in prostate cell hyperproliferation and leads to uncomf
Externí odkaz:
https://doaj.org/article/7e00155aa2b24cceb1b55b96d1fe29ec
Autor:
Wisuwat Thongphichai, Tamonwan Uttarawichien, Pithi Chanvorachote, Supaporn Pitiporn, Todsaphol Charoen-ame, Pakakrong Kwankhao, Pasarapa Towiwat, Suchada Sukrong
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Crinum latifolium L. (Amaryllidaceae) has been used in Southeast Asian traditional medicine to alleviate the symptoms of benign prostatic hyperplasia (BPH). The pathological mechanism of BPH is associated with the induction of pro
Externí odkaz:
https://doaj.org/article/d229abc69b74472da4b9b00b682ef773
Autor:
Chonnapat Naktubtim, Witchuda Payuhakrit, Tamonwan Uttarawichien, Artchaya Hassametto, Prasit Suwannalert
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 155, Iss , Pp 113757- (2022)
Colorectal cancer (CRC) progression is strongly influenced by the tumor microenvironment (TME) in which cancer-associated fibroblasts (CAFs) are the major components influencing CRC growth and progression. The present study aimed to investigate the e
Externí odkaz:
https://doaj.org/article/d19917c690ce42e098c563b9d61079fb
Autor:
Tamonwan Uttarawichien, Chantra Kamnerdnond, Tasanee Inwisai, Prasit Suwannalert, Nathawut Sibmooh, Witchuda Payuhakrit
Publikováno v:
Scientia Pharmaceutica, Vol 89, Iss 2, p 23 (2021)
Colorectal cancer (CRC) aggressiveness is caused by cancer angiogenesis which promotes the cancer growth and metastasis associated with poor prognosis and poor survival. The vascular endothelial growth factor-A (VEGF-A) and its receptor (VEGFR-2) for
Externí odkaz:
https://doaj.org/article/b4e391c7e92b427783d14092cee245f3
Autor:
Nathawut Sibmooh, Chantra Kamnerdnond, Tamonwan Uttarawichien, Witchuda Payuhakrit, Tasanee Inwisai, Prasit Suwannalert
Publikováno v:
Scientia Pharmaceutica
Volume 89
Issue 2
Scientia Pharmaceutica, Vol 89, Iss 23, p 23 (2021)
Volume 89
Issue 2
Scientia Pharmaceutica, Vol 89, Iss 23, p 23 (2021)
Colorectal cancer (CRC) aggressiveness is caused by cancer angiogenesis which promotes the cancer growth and metastasis associated with poor prognosis and poor survival. The vascular endothelial growth factor-A (VEGF-A) and its receptor (VEGFR-2) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f43ad435f020b30ff197dd0add984b
https://doi.org/10.3390/scipharm89020023
https://doi.org/10.3390/scipharm89020023